ПОДХОДЫ К ФИТОТЕРАПИИ ВИЧ-ИНФЕКЦИИ

  • Юрий Александрович Смирнов ФГБУ «ФНИЦЭМ им. Н.Ф. Гамалеи» Минздрава РФ (г. Москва)
  • Николай Николаевич Носик ФГБУ «ФНИЦЭМ им. Н.Ф. Гамалеи» Минздрава РФ (г. Москва)
  • Дмитрий Николаевич Носик ФГБУ «ФНИЦЭМ им. Н.Ф. Гамалеи» Минздрава РФ (г. Москва)
Ключевые слова: ВИЧ-инфекция, антивирусная активность, лекарственные растения, биологически активные вещества

Аннотация

Проблема борьбы с ВИЧ-инфекцией имеет огромное значение для всего мира. Поэтому поиски новых противовирусных средств являются весьма актуальными. Наряду с поисками новых синтетических препаратов проводятся изыскания антивирусных веществ растительного происхождения. В обзоре приведены общие сведения о ВИЧ-инфекции, обобщены научные данные об антивирусной активности растительных лекарственных средств. Рассматриваются механизмы этого действия биологически активных веществ лекарственных растений.

Биографии авторов

Юрий Александрович Смирнов, ФГБУ «ФНИЦЭМ им. Н.Ф. Гамалеи» Минздрава РФ (г. Москва)

Д.м.н., профессор, ведущий научный сотрудник лаборатории онтогенеза вирусов.

Николай Николаевич Носик, ФГБУ «ФНИЦЭМ им. Н.Ф. Гамалеи» Минздрава РФ (г. Москва)

Д.м.н., профессор, руководитель лаборатории онтогенеза вирусов.

Дмитрий Николаевич Носик, ФГБУ «ФНИЦЭМ им. Н.Ф. Гамалеи» Минздрава РФ (г. Москва)

Д.м.н., профессор, руководитель лаборатории вирусов иммунодефицита.

Литература

1. Бобков А.Ф., Селимова Л.М., Покровский А.Ф, Ладная Н.Н., Казеннова Е.В., Бобкова М.Р. Генетическая характеристика вариантов вируса иммунодефицита человека 1-го типа. // Вопросы вирусологии. – 1997. – №1. – С.13–16.
2. Бобкова М.Р. Иммунитет и ВИЧ-инфекция. – М.: «Олимпия-PRESS», 2006.
3. Казеннова Е.В., Нешумаев Д.А., Рукавицин Д.В. Молекулярно-эпидемиологический анализ эпидемии ВИЧ-инфекции в Благовещенске и Хабаровске (Дальний Восток России) // Вопросы вирусологии. – 2014. – №4. – С.31–36.
4. Лаповок И.А., Казеннова Е. В., Бобкова М. Р. Характеристика структуры области 5’-LTR ВИЧ-1 подтипа A, распространенного на территории России // Вопросы вирусологии. – 2009. – №2. – С.31–35.
5. Носик Д.Н., Носик Н.Н. ВИЧ-инфекция: профессиональный риск и экстренная профилактика. – М.: Издательство НЦССХ им. А.Н. Бакулева РАМН, 2004. – 55 с.
6. Покровский В.В., Ермак Т.Н., Беляева В.В., Юрин О.Г. «ВИЧ-инфекция: клиника, диагностика и лечение. –
М.: ГЭОТАР-Медиа, 2000. – 496 с.
7. Смирнов Ю.А., Киселева Т.Л., Смирнова Ю.А., Карпеев А.А. Подходы к антивирусной фитотерапии // Традиционная медицина. – 2009. – №2. – С.47–59.
8. Battinelli L., Mengoni F., Lichtner M., Mazzanti G., Saija A., Mastroianni C.M. and Vullo V., Effect of limonin and nomilin on HIV-1 replication on infected human mononuclear cells // Planta Med. – 2003. – 69, 910–913.
9. Chen K., Shi Q., Kashiwada Y., Zhang D.C., Hu C.Q., Jin J.Q., Nozaki H., Kilkuskie R.E., Tramontano E., Cheng Y.C. et al. Anti-AIDS agents. 6. Salaspermic acid, an anti-HIV principle from Tripterygium wilfordii, and the structure-activity correlation with its related compounds. J. // J. Nat. Prod. –1992. – 55: 340–346.
10. Cohen J. The many states of HIV in America // Science. – 2012. – 337, 168–171.
11. Erickson K.L., Beutler J.A., Cardellina J.H., McMahon J.B., Newman, D.J. and Boyd M.R. A novel phorbol ester from Excoecaria agallocha // J. Nat. Prod. – 1995. – 58, 769.
12. Fesen M.R., Kohn K.W., Leteurtre F. and Pommier Y. Inhibitorsof human immunodeficiency virus integrase //
Proc. Natl. Acad. Sci. USA. – 1993. – 90: 2399–2403.
13. Fujioka T. and Kashiwada Y. Anti-AIDS agents. 11. Betulinica cidandplatanic acid as anti-HIV principles from Syzigium claviflorum, and theanti-HIV activity of structurally related triterpenoids // J. Nat. Prod. – 1994. – 57:243–247.
14. Fuller R.W., Westergaard C.K., Collins J.W., Cardellina J.H., Boyd M.R. Vismiaphenomenes D-G, new prenylated benzophenones from Vismia cayennensis // J. Nat. Prod. – 1999. – 62, 67–69.
15. Futterman D. HIV/AIDS: the next generation // Science. – 2012. – 337: 799.
16. Gnabre J.N., Brady J.N., Clanton D.J., Ito Y., Dittmer J., Bates R.B. and Huang R.C.C. 1995. Inhibition of human immunodeficiency virus type 1 transcription and replication by DNA sequence-selective plant lignans // Proc. Natl. Acad. Sci. USA. – 1995. – 92: 11239–11243.
17. Higuchi H., Mori K. and Kato A. Antiretoviral activities of anthraquinones and their inhibitory effects on reverse transcription // Antiviral Res. – 1991. – 15, 205.
18. Houghton, P.J., T.Z. Woldemariam, A.I. Khan, A. Burke, and N. Mahmood. Antiviral activity of natural and semi-synthetic chromosomealkaloids // Antiviral Res. – 1994. – 25: 235–244.
19. Huang P.L., Chen H.C., Kung H.F., Huang P.L., Huang H.I. and Lee-Huang S. Anti-HIV plant proteins catalyze topological changes of DNA into inactive forms // Biofactors. – 1992. – 4:37–41.
20. Hudson J.B., Graham E.A., Harris L. and Ashwood-Smith M.J. The unusual UVA-dependent antiviral properties of the furoisocoumarin, coriandrin // Photochem. Photobiol. – 1993. – 57: 491–496.
21. Ito M., H. Nakashima, M. Baba, R. Pauwels, E. De Clercq, S. Shigeta, and N. Yamamoto.Inhibitory effect of glycyrrhizin on the in vitro infectivityand cytopathic activity of the human immunodeficiency virus [HIV(HTLV-III/LAV)]. /Antivir. Res. -1987. -7:127–137.
22. Jiratchariyakul W. HIV inhibitor from Thai bitter gourd // Planta Med. – 2001. – 67, 350–353.
23. Kaul T.N., Middletown E.Jr. and Ogra P.L. Antiviral effect offlavonoids on human viruses // J. Med. Virol. –
1985. – 15: 71–79.
24. Kim H.J., Woo E.R. and Shin C.G. A new flavonol glycoside gallate ester from Acer okamotoanum and its inhibitory activitagainst human immunodeficiency virus-1 (HIV-1) integrase // J. Nat. Prod. – 1998. – 61, 145–148.
25. Kim H.J., Yu Y.G., Park H. and Lee Y.S. HIV gp41-binding phenolic components from Fraxinussieboldiana var. angustata // Planta Med. – 2002. – 68, 1034–1036.
26. Klos M., van de Venter M., Milne P.J., Traore H.N., Meyer D. In vitro anti-HIV activivy of five selected South African mtdicinal plant extracts // J. Ethnopharmaco. – 2009. – 124: 182–188.
27. Kreis W., Kaplan M.H., Freeman J., Sun D.K. and Sarin P.S. Inhibition of HIV replication by Hyssop officinalis extracts // Antiviral Res. – 1990. – 14: 323–337.
28. Kumari G., and Singh R.K. Highly active antiretroviral therapy for treatment of HIV/AIDS patients // HIV AIDS Rev. – 2012. – 11, 5–14.
29. Lai P.K., Donovan J., Takayama H., Sakagami H., Tanaka A., Konno K. and Nonoyama M. Modification of human immunodeficiency viralreplication by pine cone extracts // AIDS Res. Hum. Retroviruses. – 1990. – 6:205–217.
30. Lee-Huang S., Huang P.L., Chen H.C., Huang P.L., Bourinbaiar A., Huang H.I. and Kung H.-F. Anti-HIV and anti-tumor activities of recombinant MAP30 from bitter melon // Gene. – 1995. – 161:151–156.
31. Lee-Huang S., Huang P.L., Bourinbaiar A.S., Chen H.C. and Kung H.F. Inhibition of the integrase of human immunodeficiency virus (HIV) type 1 by anti-HIV plant proteins MAP30 and GAP31 // Proc. Natl. Acad. Sci. USA. – 1995. – 92: 8818–8822.
32. Lee-Huang S., Kung H.F., Huang P.L., Bourinbaiar A.S., Morell J.L., Brown J.H., Huang P.L., Tsai W.P., Chen A.Y., Huang H.I. and Chen H.C. Human immunodeficiency virus type 1 (HIV-1) inhibition, DNA-binding, RNA-binding and ribosome inactivation activities in theN-terminal segments of the plant anti-HIV protein // Proc. Natl. Acad. Sci.USA. – 1994. – 91: 12208–12212.
33. Lim Y.A., Mei M.C., Kusumoto I.T., Miyashiro H. and Hattori M., HIV-1 reverse transcriptase inhibitory principles from Chamaesycehyssopifolia // Phytother. Res. – 1997. – 11, 22–27.
34. Lin Y.M., Anderson H., Flavin M.T., Pai Y.S.H. In vitro anti-HIV activity of biflavonoids isolated from Rhus succedanea and Garcinia multiflora // J. Nat. Prod. – 1997. – 60, 884–888.
35. Liul K.C.S.C., Lin M.T., Lee S.S., Chiou J.F., Ren S. and Lien E. Antiviral tannins from two Phyllanthus species // Planta Med. – 1999. – 65, 43–46.
36. Martin D.E., Blum R., Wilton J. Antimicrob. Agents Chemother. – 2007. – 51. – 3063–3066.
37. Mazumder A., Cooney D., Agbaria R. and Pommier Y. Inhibition ofhuman immunodeficiency virus type 1 integrase by 39-azido-39-deoxythymidylate // Proc. Natl. Acad. Sci. USA. – 1994. – 91:5771–5775.
38. McMahon J.B., Currens M.J., Gulakowski R.J., Buckheit R.W.J., Lackman-Smith C., Hallock Y.F. and Boyd M.R. Michellamine B, anovel plant alkaloid, inhibits human immunodeficiency virus-induced cellkilling by at least two distinct mechanisms // Antimicrob. Agents Chemother. – 1995. – 39:484–488.
39. Mekkawy S.E., Meselhy M.R. and Nakamura N. Anti-HIV-1 and anti-HIV-1 protease substances from Ganodermalucidum // Phytochem. – 1998. – 49, 1651–1657.
40. Min B.S., Jung H.J. and Lee J.S. Inhibitory effect of triterpenes from Crataegus pinatifida on HIV-1 protease //
Planta Med. – 1999. – 65, 374–375.
41. Muller W.E.G., Renneisen K., Kreuter M.H., Schroder H.C. and Winkler I. The D-mannose-specific lectin from Gerardia savaglia blocksbinding of human immunodeficiency virus type I to H9 cells and human lymphocytes in vitro // J. Acquired Immune Defic. Syndr. – 1988. – 1:453–458.
42. Murray M.T., Pizzorno J. The Encyclopedia of Natural Medicine, 3rd Edition, 1999.
43. Nakane H., Arisawa M., Fujita A., Koshimura S. and Ono K. Inhibition of HIV reverse transcriptase activity by some phloroglucinol derivatives // FEBS Lett. – 1991. – 286, 83–85.
44. Nishizawa M., Emura M., Kan Y.,Yamada, H., Ogawa, K. and Hamanaka, N., Macrocarpals: HIV-RTase inhibitors of Eucalyptus globulus. // Tetrahedron Lett. – 1992. – 33, 2983–2986.
45. Offergeld R., C. Reinecker, E. Gumz, S. Schrum, R. Treiber, R. D. Neth,and S. H. Gohla.Mitogenic activity of high molecular polysaccharide fractions isolated from the cuppressaceae Thuj aoccidentalis L. Enhancedcytokine-production by thyapolysaccharide, g-fraction (TPSg)../ Leukemia - 1992.-6(Suppl. 3):189S–191S.
46. Ogata T., Higuchi S., Mochida H., Matsumoto A., Kato T., Endo A.K. and Kaji H. HIV-1 reverse transcriptase inhibitor from Phyllanthusniruri // AIDS Res. Hum. Retroviruses. – 1992. – 1937–1944.
47. O’Keefe B.B., Vojdani F., Buffa V., Shattock R.J., Montefiori D.C., Bakke J. Scaleable manufacture of HIV-1 entry inhibitor griffithsin and validation of its safety and efficacy as a topical microbicide component // PNAS – 2009. – 106, N15: 6099–6104.
48. Ono K., H. Nakane, M. Fukushima, and F. Barre-Sinoussi. Differential inhibitory effects of various flavonoids on theactivities of reverse transcriptase and cellular DNA and RNA polymerases // Eur. J. Biochem. – 1990. – 190:469–476.
49. Ovenden S.B.P. et al. Globoidnan A: A lignan from Eucalyptus globoidea inhibits HIV integrase // Phytochemistry. – 2004. – 65, 3255–3259.
50. Paris A., Strukelj B., Renko M. and Turk V. Inhibitory effect of carnosolic acid on HIV-1 protease in cell-free assays // J. Nat. Prod. – 1993. – 56:1426–1430.
51. Pengsuparp T., Cai L., Constant H., Fong H.H., Lin L.Z., Kinghorn A.D., Pezzuto J.M., Cordell G.A., Ingolfsdottir K. and Wagner H. Mechanistic evaluation of new plant-derived compounds that inhibit HIV-1 reverse transcriptase // J. Nat. Prod. – 1995. – 58:1024–1031.
52. Pengsuparp T., Cai L., Fong H.H.S., Kinghorn A.D., Pezzuto J.M., Wani M.C. and Wall M.E. Pentacyclic triterpenes derived from Maproune aafricana are potent inhibitors of HIV-1 reverse transcriptase // J. Nat. Prod. – 1994. – 57:415–418.
53. Rimando A.M., Pezzuto J.M., Fransworth N.R., Santisuk T., Reutrakul V. and Kawanishi K., New lignans from Anogeissus acuminata with HIV-1 reverse transcriptase inhibitory activity // J. Nat. Prod. – 1994. – 57, 904–996.
54. Premanathan M., Arakaki R., Izumi H. Antivir. Res. – 1999. – 44, 113-132.
55. Rukachaisirikul V., Paice P., Hiranrat A., Tuchinda P., Yoosook C., Kasisit J. Anti-HIV-1 protostane triterpenes and digeranyl benzophenone from trunk bark and stems of Garciniaspeciosa // Planta Med. – 2003. – 69, 1141–1146.
56. Sakurai N., Wu J.H., Sashida Y., Minaki Y., Nikaido T., Koike K. Anti-AIDS agents // Bioorg. Med. Chem. Lett. – 2004. – 14(5). – 1329–1332.
57. Saxena S.K., Tiwari S. and Nair M.P. A global perspective on HIV/AIDS // Science. – 2012. –337:798.
58. Short R.V. New ways of preventing HIV infection // Philos. Trans. R. Soc. Lond. B Biol. Sci. – 2006. – 361, 811–820.
59. Spedding, G., Ratty A. and Middleton E.J. Inhibition of reverse transcriptases by flavonoids // Antiviral Res. – 1989. – 12:99–110.
60. Sun H.D., Qiu S.X., Lin L.Z., Wang Z.Y., Lin Z.W., Pengsuparp T., Pezzuto J.M., Fong H.H., Cordell G.A. and Farnsworth N.R. Nigranoicacid, a triterpenoid from Schisandra sphaerandra that inhibits HIV-1 reversetranscriptase // J. Nat. Prod. – 1996. – 59: 525–527.
61. Tan G.T., Miller J.F., Kinghorn A.D., Hughes S.H. and Pezzuto J.M. HIV-1 and HIV-2 reverse transcriptases: a comparative study ofsensitivity to inhibition by selected natural products // Biochem. Biophys. Res. Commun. – 1992. – 185:370–378.
62. Tan G.T., Pezzuto J.M., Kinghorn A.D. and Hughes S.H. Evaluation of natural products as inhibitors of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase // J. Nat. Prod. – 1991. – 54:143–154.
63. UNAIDS (2010). UNAIDS Report on the Global AIDS Epidemic 2010. – Geneva.
64. Vermani K. and Garg S.J. Ethnopharmacol. – 2002. – 80, 49–66.
65. Watanabe H., Miyaji C., Makino M. and Abo T. Therapeutic effects of glycyrrhizin in mice infected with LP-BM5 murine retrovirus and mechanisms involved in the prevention of disease progression // Biotherapy. – 1996. – 9: 209–220.
66. World Health Organization. Report of WHO Informal Consultation on Traditional Medicine and AIDS. Geneva, February 1989.
67. Xu H.X., Zeng F.Q., Wan M. and Sim K.Y. Anti-HIV triterpene acids from Geum japonicum // J. Nat. Prod. – 1996. – 59: 643–645.
68. Yang X.W., Zhao J., Cui Y.X., Liu X.H. Anti-HIV-1 protease triterpenoid saponins from the seeds of Aesculus chinensis // J. Nat. Prod. 1999. – 62. – 1510–1513.
69. Yao X.-J., Wainberg M.A. and Parniak M.A. Mechanism of inhibition of HIV-1 infection in vitro by purified extract of Prunella vulgaris // Virology. – 1992. – 178:56.
70. Yoshida T., Ito H., Hatano T., Kurata M., Nakanishi T., Inada A., Murata H. New hydrolysable tannins, shephagenins A and B from Shepherdia argentea as HIV-1 reverse transcriptase inhibitors // Chemical Pharm. Bull. –
1996. – 44, 1436–1439.
Опубликован
2017-12-21
Как цитировать
[1]
Ю. Смирнов, Н. Носик, и Д. Носик, ПОДХОДЫ К ФИТОТЕРАПИИ ВИЧ-ИНФЕКЦИИ, tm, вып. 4(51) 2017, сс. 26-35, дек. 2017.
Выпуск
Раздел
Натуротерапия